Journal article
Adverse Events Associated with High‐Dose Ribavirin: Evidence from the Toronto Outbreak of Severe Acute Respiratory Syndrome
Abstract
STUDY OBJECTIVES: To distinguish adverse events related to ribavirin therapy from those attributable to severe acute respiratory syndrome (SARS), and to determine the rate of potential ribavirin-related adverse events.
DESIGN: Retrospective cohort study.
Authors
Muller MP; Dresser L; Raboud J; McGeer A; Rea E; Richardson SE; Mazzulli T; Loeb M; Louie M
Journal
Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy, Vol. 27, No. 4, pp. 494–503
Publisher
Wiley
Publication Date
April 2007
DOI
10.1592/phco.27.4.494
ISSN
0277-0008
Associated Experts
Fields of Research (FoR)
Sustainable Development Goals (SDG)
Medical Subject Headings (MeSH)
Adrenal Cortex HormonesAdultAdverse Drug Reaction Reporting SystemsAnemiaAntiviral AgentsBradycardiaCanadaCohort StudiesDisease OutbreaksDose-Response Relationship, DrugFemaleHumansInjections, IntravenousMagnesium DeficiencyMaleMedical Records Systems, ComputerizedMiddle AgedRetrospective StudiesRibavirinSevere Acute Respiratory SyndromeTetanyTreatment Outcome